|
[1]
|
Balkwill, F. and Mantovani, A. (2001) Inflammation and Cancer: Back to Virchow? The Lancet, 357, 539-545. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Mantovani, A., Allavena, P., Sica, A. and Balkwill, F. (2008) Cancer-Related Inflammation. Nature, 454, 436-444. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Colotta, F., Allavena, P., Sica, A., Garlanda, C. and Mantovani, A. (2009) Cancer-Related Inflammation, the Seventh Hallmark of Cancer: Links to Genetic Instability. Carcinogenesis, 30, 1073-1081. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
McNally, M.E., Martinez, A., Khabiri, H., Guy, G., Michaels, A.J., Hanje, J., et al. (2012) Inflammatory Markers Are Associated with Outcome in Patients with Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Annals of Surgical Oncology, 20, 923-928. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Fan, W., Zhang, Y., Wang, Y., Yao, X., Yang, J. and Li, J. (2015) Neutrophil-to-Lymphocyte and Platelet-To-Lymphocyte Ratios as Predictors of Survival and Metastasis for Recurrent Hepatocellular Carcinoma after Transarterial Chemoembolization. PLOS ONE, 10, e0119312. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Li, X., Chen, Z., Xing, Y., Wang, T., Wu, D., Wen, J., et al. (2014) Platelet-To-Lymphocyte Ratio Acts as a Prognostic Factor for Patients with Advanced Hepatocellular Carcinoma. Tumor Biology, 36, 2263-2269. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Xia, W., Ke, Q., Wang, Y., Wang, W., Zhang, M., Shen, Y., et al. (2015) Predictive Value of Pre-Transplant Platelet to Lymphocyte Ratio for Hepatocellular Carcinoma Recurrence after Liver Transplantation. World Journal of Surgical Oncology, 13, Article No. 60. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Kabir, T., Ye, M., Mohd Noor, N.A., Woon, W., Junnarkar, S.P. and Shelat, V.G. (2019) Preoperative Neutrophil-to-Lymphocyte Ratio Plus Platelet-To-Lymphocyte Ratio Predicts the Outcomes after Curative Resection for Hepatocellular Carcinoma. International Journal of Hepatology, 2019, Article ID: 4239463. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Xue, T., Jia, Q., Ge, N., Zhang, B., Wang, Y., Ren, Z., et al. (2015) The Platelet-To-Lymphocyte Ratio Predicts Poor Survival in Patients with Huge Hepatocellular Carcinoma That Received Transarterial Chemoembolization. Tumor Biology, 36, 6045-6051. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Shimura, T., Shibata, M., Gonda, K., Hayase, S., Sakamoto, W., Okayama, H., et al. (2018) Prognostic Impact of Preoperative Lymphocyte-To-Monocyte Ratio in Patients with Colorectal Cancer with Special Reference to Myeloid-Derived Suppressor Cells. Fukushima Journal of Medical Science, 64, 64-72. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Koh, C., Bhoo-Pathy, N., Ng, K., Jabir, R.S., Tan, G., See, M., et al. (2015) Utility of Pre-Treatment Neutrophil-Lymphocyte Ratio and Platelet–lymphocyte Ratio as Prognostic Factors in Breast Cancer. British Journal of Cancer, 113, 150-158. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Lieto, E., Galizia, G., Auricchio, A., Cardella, F., Mabilia, A., Basile, N., et al. (2017) Preoperative Neutrophil to Lymphocyte Ratio and Lymphocyte to Monocyte Ratio Are Prognostic Factors in Gastric Cancers Undergoing Surgery. Journal of Gastrointestinal Surgery, 21, 1764-1774. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Stotz, M., Pichler, M., Absenger, G., Szkandera, J., Arminger, F., Schaberl-Moser, R., et al. (2014) The Preoperative Lymphocyte to Monocyte Ratio Predicts Clinical Outcome in Patients with Stage III Colon Cancer. British Journal of Cancer, 110, 435-440. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Basse, L., Hjort Jakobsen, D., Billesbølle, P., Werner, M. and Kehlet, H. (2000) A Clinical Pathway to Accelerate Recovery after Colonic Resection. Annals of Surgery, 232, 51-57. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Coolsen, M.M.E., Wong‐Lun‐Hing, E.M., van Dam, R.M., van der Wilt, A.A., Slim, K., Lassen, K., et al. (2013) A Systematic Review of Outcomes in Patients Undergoing Liver Surgery in an Enhanced Recovery after Surgery Pathways. HPB, 15, 245-251. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
MacKay, G. and O’Dwyer, P. (2008) Early Discharge Following Liver Resection for Colorectal Metastases. Scottish Medical Journal, 53, 22-24. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Ni, C.Y., Yang, Y., Chang, Y.Q., Cai, H., Xu, B., Yang, F., et al. (2013) Fast-Track Surgery Improves Postoperative Recovery in Patients Undergoing Partial Hepatectomy for Primary Liver Cancer: A Prospective Randomized Controlled Trial. European Journal of Surgical Oncology (EJSO), 39, 542-547. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Lin, D., Li, X., Ye, Q., Lin, F., Li, L. and Zhang, Q. (2011) Implementation of a Fast-Track Clinical Pathway Decreases Postoperative Length of Stay and Hospital Charges for Liver Resection. Cell Biochemistry and Biophysics, 61, 413-419. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
van Dam, R.M., Hendry, P.O., Coolsen, M.M.E., Bemelmans, M.H.A., Lassen, K., Revhaug, A., et al. (2008) Initial Experience with a Multimodal Enhanced Recovery Programme in Patients Undergoing Liver Resection. British Journal of Surgery, 95, 969-975. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Hendry, P.O., van Dam, R.M., Bukkems, S.F.F.W., McKeown, D.W., Parks, R.W., Preston, T., et al. (2010) Randomized Clinical Trial of Laxatives and Oral Nutritional Supplements within an Enhanced Recovery after Surgery Protocol Following Liver Resection. British Journal of Surgery, 97, 1198-1206. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Jones, C., Kelliher, L., Dickinson, M., Riga, A., Worthington, T., Scott, M.J., et al. (2013) Randomized Clinical Trial on Enhanced Recovery versus Standard Care Following Open Liver Resection. British Journal of Surgery, 100, 1015-1024. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Stoot, J.H., Van Dam, R.M., Busch, O.R., Van Hillegersberg, R., De Boer, M., Olde Damink, S.W.M., et al. (2009) The Effect of a Multimodal Fast-Track Programme on Outcomes in Laparoscopic Liver Surgery: A Multicentre Pilot Study. HPB, 11, 140-144. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Templeton, A.J., McNamara, M.G., Šeruga, B., Vera-Badillo, F.E., Aneja, P., Ocaña, A., et al. (2014) Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-analysis. JNCI: Journal of the National Cancer Institute, 106, dju124. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Huang, L., Liu, S., Lei, Y., Wang, K., Xu, M., Chen, Y., et al. (2016) Systemic Immune-Inflammation Index, Thymidine Phosphorylase and Survival of Localized Gastric Cancer Patients after Curative Resection. Oncotarget, 7, 44185-44193. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Kim, E.Y., Lee, J.W., Yoo, H.M., Park, C.H. and Song, K.Y. (2015) The Platelet-To-Lymphocyte Ratio versus Neutrophil-to-Lymphocyte Ratio: Which Is Better as a Prognostic Factor in Gastric Cancer? Annals of Surgical Oncology, 22, 4363-4370. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Meng, X., Chang, Q., Liu, Y., Chen, L., Wei, G., Yang, J., et al. (2018) Determinant Roles of Gender and Age on SII, PLR, NLR, LMR and MLR and Their Reference Intervals Defining in Henan, China: A Posteriori and Big‐Data‐Based. Journal of Clinical Laboratory Analysis, 32, e22228. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Luo, H., He, L., Zhang, G., Yu, J., Chen, Y., Yin, H., et al. (2019) Normal Reference Intervals of Neutrophil-to-Lymphocyte Ratio, Platelet-To-Lymphocyte Ratio, Lymphocyte-To-Monocyte Ratio, and Systemic Immune Inflammation Index in Healthy Adults: A Large Multi-Center Study from Western China. Clinical Laboratory, 65. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Forget, P., Khalifa, C., Defour, J., Latinne, D., Van Pel, M. and De Kock, M. (2017) What Is the Normal Value of the Neutrophil-to-Lymphocyte Ratio? BMC Research Notes, 10, Article No. 12. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Kaplan, K., Broekman, M., Chernoff, A., Lesznik, G. and Drillings, M. (1979) Platelet α-Granule Proteins: Studies on Release and Subcellular Localization. Blood, 53, 604-618. [Google Scholar] [CrossRef]
|
|
[30]
|
Assoian, R.K. and Sporn, M.B. (1986) Type Beta Transforming Growth Factor in Human Platelets: Release during Platelet Degranulation and Action on Vascular Smooth Muscle Cells. The Journal of cell biology, 102, 1217-1223. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Lin, R.J., Afshar-Kharghan, V. and Schafer, A.I. (2014) Paraneoplastic Thrombocytosis: The Secrets of Tumor Self-Promotion. Blood, 124, 184-187. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Liu, C.H., Chang, S., Narko, K., Trifan, O.C., Wu, M., Smith, E., et al. (2001) Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice. Journal of Biological Chemistry, 276, 18563-18569. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Schoppmann, S.F., Birner, P., Stöckl, J., Kalt, R., Ullrich, R., Caucig, C., et al. (2002) Tumor-Associated Macrophages Express Lymphatic Endothelial Growth Factors and Are Related to Peritumoral Lymphangiogenesis. The American Journal of Pathology, 161, 947-956. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
de Visser, K.E., Eichten, A. and Coussens, L.M. (2006) Paradoxical Roles of the Immune System during Cancer Development. Nature Reviews Cancer, 6, 24-37. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Liu, C., Hu, Q., Hu, K., Su, H., Shi, F., Kong, L., et al. (2019) Increased CD8+CD28+ T Cells Independently Predict Better Early Response to Stereotactic Ablative Radiotherapy in Patients with Lung Metastases from Non-Small Cell Lung Cancer. Journal of Translational Medicine, 17, Article No. 120. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Zhou, Y., Liao, Q., Li, X., Wang, H., Wei, F., Chen, J., et al. (2016) HYOU1, Regulated by LPLUNC1, Is Up-Regulated in Nasopharyngeal Carcinoma and Associated with Poor Prognosis. Journal of Cancer, 7, 367-376. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Iezzi, R., Pompili, M., Posa, A., Annicchiarico, E., Garcovich, M., Merlino, B., et al. (2017) Transradial versus Transfemoral Access for Hepatic Chemoembolization: Intrapatient Prospective Single-Center Study. Journal of Vascular and Interventional Radiology, 28, 1234-1239. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Yamada, R., Bracewell, S., Bassaco, B., Camacho, J., Anderson, M.B., Conrad, A., et al. (2018) Transradial versus Transfemoral Arterial Access in Liver Cancer Embolization: Randomized Trial to Assess Patient Satisfaction. Journal of Vascular and Interventional Radiology, 29, 38-43. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Liu, C., Jia, B., Zou, B., Du, H., Yan, L., Yang, J., et al. (2017) Neutrophil-to-Lymphocyte and Aspartate-to-Alanine Aminotransferase Ratios Predict Hepatocellular Carcinoma Prognosis after Transarterial Embolization. Medicine, 96, e8512. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Nicolini, D., Agostini, A., Montalti, R., Mocchegiani, F., Mincarelli, C., Mandolesi, A., et al. (2017) Radiological Response and Inflammation Scores Predict Tumour Recurrence in Patients Treated with Transarterial Chemoembolization before Liver Transplantation. World Journal of Gastroenterology, 23, 3690-3701. [Google Scholar] [CrossRef] [PubMed]
|